BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 8767105)

  • 21. Breath-hold MR measurements of fat fraction, T1 , and T2 * of water and fat in vertebral bone marrow.
    Le Ster C; Gambarota G; Lasbleiz J; Guillin R; Decaux O; Saint-Jalmes H
    J Magn Reson Imaging; 2016 Sep; 44(3):549-55. PubMed ID: 26918280
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Measurement of vertebral bone marrow proton density fat fraction in children using quantitative water-fat MRI.
    Ruschke S; Pokorney A; Baum T; Eggers H; Miller JH; Hu HH; Karampinos DC
    MAGMA; 2017 Oct; 30(5):449-460. PubMed ID: 28382554
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Lipid/water ratio of bone marrow measured by phase-encoded proton nuclear magnetic resonance spectroscopy.
    Richards TL; Davis CA; Barker BR; Beinert WD; Genant HK
    Invest Radiol; 1987 Sep; 22(9):741-6. PubMed ID: 3679764
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A prospective study of autologous bone marrow or peripheral blood stem cell transplantation after intensive chemotherapy in myelodysplastic syndromes. Groupe Français des Myélodysplasies. Group Ouest-Est d'étude des Leucémies aiguës myéloïdes.
    Wattel E; Solary E; Leleu X; Dreyfus F; Brion A; Jouet JP; Hoang-Ngoc L; Maloisel F; Guerci A; Rochant H; Gratecos N; Casassus P; Janvier M; Brice P; Lepelley P; Fenaux P
    Leukemia; 1999 Apr; 13(4):524-9. PubMed ID: 10214857
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A comparison of chimerism and minimal residual disease between four different allogeneic transplantation methods in patients with chronic myelogenous leukemia in first chronic phase.
    Elmaagacli AH; Runkel K; Steckel N; Opalka B; Trenschel R; Seeber S; Schaefer UW; Beelen DW
    Bone Marrow Transplant; 2001 Apr; 27(8):809-15. PubMed ID: 11477437
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Lipid selective MR imaging and localized 1H spectroscopy of bone marrow during therapy of leukemia.
    Schick F; Einsele H; Lutz O; Claussen CD
    Anticancer Res; 1996; 16(3B):1545-51. PubMed ID: 8694524
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Extent and time course of morphological changes of bone marrow induced by granulocyte-colony stimulating factor as assessed by magnetic resonance imaging of healthy blood stem cell donors.
    Altehoefer C; Bertz H; Ghanem NA; Langer M
    J Magn Reson Imaging; 2001 Aug; 14(2):141-6. PubMed ID: 11477672
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Hematopoietic stem cell transplantation for treatment of acute leukemia].
    Harada M
    Gan To Kagaku Ryoho; 1999 Sep; 26(10):1387-95. PubMed ID: 10500524
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Age- and sex-specific differences in the 1H-spectrum of vertebral bone marrow.
    Kugel H; Jung C; Schulte O; Heindel W
    J Magn Reson Imaging; 2001 Feb; 13(2):263-8. PubMed ID: 11169833
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Bone marrow fat content in 70 adolescent girls with anorexia nervosa: Magnetic resonance imaging and magnetic resonance spectroscopy assessment.
    Ecklund K; Vajapeyam S; Mulkern RV; Feldman HA; O'Donnell JM; DiVasta AD; Gordon CM
    Pediatr Radiol; 2017 Jul; 47(8):952-962. PubMed ID: 28432403
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Myeloablative chemotherapy with autologous bone marrow and/or peripheral blood stem cell transplantation in children with high-risk solid tumor].
    Endo M; Tanosaki R
    Gan To Kagaku Ryoho; 1995 Oct; 22(12):1762-70. PubMed ID: 7574807
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Bone marrow after autologous blood stem cell transplantation and total body irradiation: magnetic resonance and chemical shift imaging.
    Kauczor HU; Brix G; Dietl B; Jarosch K; Knopp MV; van Kaick G
    Magn Reson Imaging; 1993; 11(7):965-75. PubMed ID: 7901727
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Faster engraftment but no reduction in infectious complications after peripheral blood stem cell transplantation compared to autologous bone marrow transplantation.
    Larsson K; Björkstrand B; Ljungman P
    Support Care Cancer; 1998 Jul; 6(4):378-83. PubMed ID: 9695206
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Autologous transplantation for aggressive non-Hodgkin's lymphoma: results of a randomized trial evaluating graft source and minimal residual disease.
    Vose JM; Sharp G; Chan WC; Nichols C; Loh K; Inwards D; Rifkin R; Bierman PJ; Lynch JC; Weisenburger DD; Kessinger A; Armitage JO
    J Clin Oncol; 2002 May; 20(9):2344-52. PubMed ID: 11981006
    [TBL] [Abstract][Full Text] [Related]  

  • 35. 3-Tesla MR spectroscopy in patients subjected to bone marrow transplantation: clinical correlations.
    Sergiacomi G; Gaspari E; Taglieri A; Meschini A; Gisone V; Cudillo L; Arcese W; Simonetti G
    Radiol Med; 2013 Feb; 118(1):101-11. PubMed ID: 22327923
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Determination of 1H relaxation times of water in human bone marrow by fat-suppressed turbo spin echo in comparison to MR spectroscopic methods.
    Träber F; Block W; Layer G; Bräucker G; Gieseke J; Kretzer S; Hasan I; Schild HH
    J Magn Reson Imaging; 1996; 6(3):541-8. PubMed ID: 8724421
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Autologous peripheral blood stem cell transplantation combined with autologous bone marrow transplantation for treating refractory lymphoma].
    Chen XL; Su H; Zhong KL; DA Y; Xiao XB; Liu J; Yu JD; Zhang WJ
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2009 Feb; 17(1):155-9. PubMed ID: 19236769
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Myelodysplasia and acute leukemia following high-dose chemotherapy and autologous bone marrow or peripheral blood stem cell transplantation.
    Sobecks RM; Le Beau MM; Anastasi J; Williams SF
    Bone Marrow Transplant; 1999 Jun; 23(11):1161-5. PubMed ID: 10382956
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Comparison of interferon tolerance after autologous bone marrow or peripheral blood stem cell transplants for myeloma patients who have responded to induction therapy.
    Powles R; Raje N; Horton C; Mehta J; Singhal S; Hickish T; Viner C; Milan S; Treleaven J; Cunningham D
    Leuk Lymphoma; 1996 May; 21(5-6):421-7. PubMed ID: 9172806
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Assessment and characterization of the cytolytic T lymphocyte response against Epstein-Barr virus in patients with non-Hodgkin's lymphoma after autologous peripheral blood stem cell transplantation.
    Nolte A; Buhmann R; Straka C; Emmerich B; Hallek M
    Bone Marrow Transplant; 1998 May; 21(9):909-16. PubMed ID: 9613783
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.